A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 14,519 shares of IBRX stock, worth $38,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,519
Previous 13,819 5.07%
Holding current value
$38,039
Previous $87,000 37.93%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$3.32 - $6.7 $2,324 - $4,690
700 Added 5.07%
14,519 $54,000
Q2 2024

Jul 26, 2024

SELL
$4.82 - $9.15 $3,041 - $5,773
-631 Reduced 4.37%
13,819 $87,000
Q1 2024

Apr 24, 2024

SELL
$3.23 - $6.17 $1,615 - $3,085
-500 Reduced 3.34%
14,450 $78,000
Q2 2023

Jul 13, 2023

BUY
$1.53 - $6.41 $1,530 - $6,410
1,000 Added 7.17%
14,950 $42,000
Q1 2023

May 11, 2023

BUY
$1.35 - $4.78 $2,700 - $9,560
2,000 Added 16.74%
13,950 $25,000
Q4 2022

Feb 08, 2023

BUY
$4.35 - $6.77 $51,982 - $80,901
11,950 New
11,950 $61,000
Q3 2021

Nov 02, 2021

SELL
$9.17 - $14.24 $261,968 - $406,808
-28,568 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$13.41 - $22.4 $383,096 - $639,923
28,568 New
28,568 $407,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.